Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 5:50 AM UTC
| NCT Number | NCT06963827 |
| Recruiting Status | Recruiting |
| Condition | IgA Nephropathy |
| Phase | PHASE3 |
| Target Enrollment | 347 participants |
| Active Locations | 41 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | September 30, 2026 (2 weeks ago) |
As of October 16, 2026: Clinical trial NCT06963827 is currently recruiting participants. This phase3 study for iga nephropathy is actively seeking new participants at 41 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06963827 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06963827 was last updated 2 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.